Jiang M, Milner J. Selective silencing of viral gene expression in HPVpositive human cervical carcinoma cells treated with siRNA, a primer of RNA interference[J]. Oncogene, 2002, 21(39): 6041-6048.
[4]
Thierry F, Benotmane M A, Demeret C, et al. A genomic approach reveals a novel mitotic pathway in pap illomavirus carcinogenesis[J]. Cancer Research, 2004, 64(3): 895-903.
[5]
拉莱·苏祖克, 彭玉华, 周康, 等. 新疆不同民族宫颈癌发病趋势分析[J]. 新疆医科大学学报. 2006, 29 (7): 569-571. Suzuke Lalai, Peng Yuhua, Zhou Kang, et al. The analysis of pathogenetic tendency of cervical cancer in various ethnic women in Xinjiang[J]. Journal of Xinjiang Medical University, 2006, 29(7): 569-571.
[6]
Egger G, Liang G, Aparicio A, et al. Epigenetics in human disease and prospects for epigenetic therapy[J]. Nature, 2004, 429(27): 457-463.
[7]
Esteller M. CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future[J]. Oncogene, 2002, 21(35): 5427-5440.
[8]
Yoo C B, Jones P A. Epigenetic therapy of cancer: Past, present and future[J]. Nature Reviews Drug Discovery, 2006, 5(1): 37-50.
[9]
刘深基, 陈松森. 降钙素/降钙素基因相关肤基因前体RNA的加工[J]. 国外医学分子生物学分册. 1999, 21(4): 196-200. Liu Shenji, Chen Songsen. prRNA processing of calcitonin and calcitonin gene related peptide[J]. Foreign Medical Sciences, 1999, 21(4): 196-200.
[10]
阿娜古丽·阿巴白克力, 哈尼克孜·吐尔逊, 阿布力孜·阿布杜拉, 等. 维吾尔族妇女宫颈癌及HPV感染与多种基因表达上调的关系[J]. 科 技导报, 2012, 30(19): 50-54. Ababaikeli Anaguli, Tuerxun Hankiz, Abudula Abulizi, et al. Relationship of cervical cancer of uighur women and HPV infection with the up-regulation of multiple gene expression[J]. Science & Technology Review, 2012, 30(19): 50-54.
[11]
阿仙姑·哈斯木, 李巧稚, 马俊旗, 等. 维吾尔族患者宫颈病变中内质 网分子伴侣和HLA-Ⅰ类分子表达与HPV16感染的关系研究[J]. 实 用妇产科杂志, 2011, 27(2): 102-105. Ayshamgul Hasimu, Li Qiaozhi, Ma Junqi, et al. Expression of HLA-I antigen and endoplasmic reticulum molecular chaperones in uighur cervical lesions and their association with HPV16 infection[J]. Journal of Practical Obstetrics and Gynecology, 2011, 27(2): 102-105.
[12]
李巧稚, 阿提开姆·阿布都克热木, 王燕, 等. 子宫颈癌中Smad4和 Runx3表达与HPV16感染的关系[J]. 临床与实验病理学杂志, 2012, 28(10): 1112-1115. Li Qiaozhi, Atikaimu Abudurehemu, Wang Yan, et al. Expression of Smad4 and Runx3 in cervical lesions and their association with HPV16 infection[J]. Chinese Journal of Clinical and Experimental Pathology, 2012, 28(10): 1112-1115.
[13]
邓水秀, 秦旭平. 降钙素基因相关肽的血管生物学功能多样性[J]. 国 际病理科学与临床杂志, 2006, 26(3): 246-249. Deng Shuixiu, Qin Xuping. Multiple vascular bioactivity of calcitonin gene-related peptide[J]. Journal of International Pathology and Clinical Medicine, 2006, 26(3): 246-249.
[14]
Hu S, Ewertz M, Tufano R P, et al. Detection of serum deoxyribonucleic acid methylation markers: A novel diagnostic tool for thyroid cancer[J]. The Journal of Clinical Endocrinology and Metabolism, 2006, 91(1): 98-104.
[15]
Widschwendter A, Müller H M, Fiegl H, et al. DNA methylation in serum and tumors of cervical cancer patients[J]. Clinical Cancer Research, 2004, 10(2): 565-571.
[16]
Wisman G, Nijhuis E, Hoque M, et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia[J]. International Journal of Cancer, 2006, 119(8): 1908-1914.
[17]
盛磊, 阿仙姑·哈斯木, 刘开江, 等. 维吾尔族妇女宫颈病变病理进程 与降钙素相关肽α表达的关系[J]. 癌变·畸变·突变. 2011, 23(4): 287-290. Sheng Lei, Hasimu Axiangu, Liu Kaijiang, et al. The association of cervical lesion pathogenesis in Uighur women with the protein expression of calcitoninrelated polypeptide alpha[J]. Carcinogenesis, Teratogenesis and Mutagenesis, 2011, 23(4): 287-290.
[18]
吐尔逊帕夏·吾布力卡斯木, 阿比达·阿布都卡德尔, 盛磊, 等. 维吾尔 族妇女宫颈病变与CALCA 基因启动子甲基化的关系[J]. 癌变·畸变· 突变, 2013, 25(2): 134-138. Wubulikasimu Tuerxunpaxia, Abudoukadeer Abida, Sheng Lei, et al. The association of cervical lesion pathogenesis in Uighur women and promoter methylation of CALCA gene[J]. Carcinogenesis, Teratogenesis and Mutagenesis, 2013, 25(2): 134-138.
[19]
Monsonego J. HPV infections and cervical cancer prevention. Priorities and new directions[J]. Gynecologic Oncology, 2005, 96(3): 830-839.
[20]
Wiley D, Masongsong E. Human papillomavirus: the burden of infection[J]. Obstetrical & Gynecological Survey, 2006, 61(6): 3-14.
[21]
Munoz N, Bosch F X, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. The New England Journal of Medicine, 2003, 348: 518-527.
[22]
Shames D S, Girard L, Gao B, et al. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies[J]. PLOS Medicine, 2006, 3(12): 2244-2263.
[23]
古扎丽努尔, 彭芝兰, 郭英, 等. HPV及其亚型在四川西北地区汉族 及新疆南部地区维吾尔族妇女宫颈癌组织中的差异表达[J]. 中华微 生物学和免疫学杂志, 2004, 24(5): 408. Guzhalinuer, Peng Zhilan, Guo Ying, et al. Different expression of HPV and its subtypes in northwest sichuan han and southern xinjiang uygur women cervical cancer tissue[J]. Chinese Journal of Microbiology and Immunology, 2004, 24(5): 408.
[24]
Holland D, Hoppe-Seyler K, Schuller B, et a1. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein[J]. Cancer Research, 2008, 68(23): 9964-9972.
